Multiomic Analysis of Serum in Acute Period of Traumatic Brain Injury

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this experimental observation study is to figure out differently expressed biomarkers in serum in traumatic brain injury patients, compared with bone fracture patients. The main questions it aims to answer are:

1. Which proteins and metabolites are differently expressed in TBI patients' serum?
2. Which proteins or metabolites can serve as the new serum biomarkers for diagnosing TBI? Participants will be treated by routine treatments, and their serum samples will be collected in the emergency room.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multiomic Analysis of Body Fluid in Acute Traumatic Brain Injury

NCT05778123

Brain Injuries, Traumatic

UNKNOWN

Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue

NCT05778110

Brain Injury Traumatic Severe Intracranial Hemorrhage, Hypertensive

UNKNOWN

Rapid Diagnosis and Prognosis Recognition of Imaging and Biomarkers in Mild to Moderate Traumatic Brain Injury

NCT05108909

MTBI - Mild Traumatic Brain Injury Moderate Traumatic Brain Injury

UNKNOWN

A Study of Biomarkers of Mild Traumatic BRAIN Injury

NCT04032509

Mild Traumatic Brain Injury

COMPLETED

The Research for New Clinical Diagnostic Strategy of Specific Biomarkers for Traumatic Brain Injury

NCT03976492

Traumatic Brain Injury

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This experimental observation study is designed to find out some new characteristics in acute severe traumatic brain injury. To filter the stress response in blood, patients with traumatic fracture are chosen as the control group.

Blood samples of patients who pass the eligibility criteria will be collected immediately in the emergency room. Then the samples will be preprocessed in the laboratory to get serums. These collected serums will be preserved in -80℃ until completing all sample collection. After completing collection, all samples will be sent to proteomic and metabolomic detection. The bioinformatic data will be analyzed to answer these main questions:

1. Which proteins and metabolites are differently expressed in TBI patients' serum? (As a whole characteristic of acute severe TBI)
2. Which proteins or metabolites can serve as the new serum biomarkers for diagnosing TBI? (Deeply digging the value of characteristic of acute severe TBI)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case group

This group enrolls patients with acute severe traumatic brain injury.

Type of trauma

Intervention Type OTHER

Patients in case group have the severe traumatic brain injury, while patients in control group have the traumatic bone fracture without brain injury.

Control group

This group enrolls patients with acute traumatic bone fracture but without traumatic brain injury.

Type of trauma

Intervention Type OTHER

Patients in case group have the severe traumatic brain injury, while patients in control group have the traumatic bone fracture without brain injury.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Type of trauma

Patients in case group have the severe traumatic brain injury, while patients in control group have the traumatic bone fracture without brain injury.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* With cerebral contusion in 24Hrs for case group, or with traumatic bone fracture in 24Hrs for control group.
* The Glasglow Coma Scale ranges in 3-8 for case group.
* Need to have routine laboratory examination of blood sample.
* Patients or agents sign the informed consent.

Exclusion Criteria

* With bone fracture for case group, or with brain injury for control group.
* Have Orthopaedic history for case group, or have Neurological history for control group.
* Death in 24 hours.
* Immunosuppressed state.
* Severe multiple organ dysfunction.
* With infection.
* Pregnant.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No